Identification of differential expressed genes and its related pathways in Hela cell line treated with urea noscapine as potent anticancer agent

Animesh Pattnaik Pradeep Kumar Naik   

Open Access   

Published:  May 02, 2024

DOI: 10.7324/JABB.2024.156861

Noscapinoids, synthetic derivatives of noscapine, have been identified as potential anticancer drugs in cervical cancer. This study aimed to understand the mechanism of action of noscapinoids by comparing the gene expression profiles of treated and untreated Hela cells using RNA-seq. A total of 4926 differentially expressed genes (DEGs) were identified, including BAG2, BCL2L11, HSPA4, CASP14, CASP12, CASP8, CASP10, CASP1, and CFLAR. Pathway analysis revealed 20 enriched pathways from up and downregulated DEGs, including endoproteases, cysteine-type endopeptidase activity, TNF, IL-17 signaling pathway, Mitophagy, and Shigellosis. A detailed investigation into DEGs using annotations for cellular components, molecular functions, and biological processes identified different 20 regulating activities from both up and downregulating DEGs. To determine the 50 most functional genes from each group, a protein-protein interaction network was built. These genes were then subjected to further testing by reverse transcription polymerase chain reaction. It was discovered that the downregulated genes that were the focus of the investigation were related to tumor cell invasion, migration and motility, and cell survival and proliferation. The study suggests that these DEGs could be targeted for therapeutic purposes and may serve as potential biomarkers for developing novel therapeutic approaches in cancer treatment. The research sheds light on the mechanism of action of noscapinoids and highlights their potential as a new class of anticancer drugs.

Keyword:     Noscapinoids Noscapine Potential anticancer Hela cells RNA-seq Reverse transcription polymerase chain reaction Differentially expressed genes


Pattnaik A, Naik PK. Identification of differential expressed genes and its related pathways in Hela cell line treated with urea noscapine as potent anticancer agent. J App Biol Biotech. 2024. Online First.

Copyright: Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

HTML Full Text

1. Diab N, Patel M, O'Byrne P, Satia I. Narrative review of the mechanisms and treatment of cough in asthma, cough variant asthma, and non-asthmatic eosinophilic bronchitis. Lung 2022;200:707-16.

2. Ye K, Ke Y, Keshava N, Shanks J, Kapp JA, Tekmal RR, et al. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. Proc Natl Acad Sci U S A 1998;95:1601-6.

3. Halim F, Azhar Y, Suwarman S, Hernowo B. p53 mutation as plausible predictor for endocrine resistance therapy in luminal breast cancer. F1000Res 2022;11:330.

4. Landen JW, Lang R, McMahon SJ, Rusan NM, Yvon AM, Adams AW, et al. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res 2002;62:4109-14.

5. Groneberg-Kloft B, Feleszko W, Dinh QT, van Mark A, Brinkmann E, Pleimes D, et al. Analysis and evaluation of environmental tobacco smoke exposure as a risk factor for chronic cough. Cough 2007;3:6.

6. Pengnam S, Plianwong S, Yingyongnarongkul BE, Patrojanasophon P, Opanasopit P. Delivery of small interfering RNAs by nanovesicles for cancer therapy. Drug Metab Pharmacokinet 2022;42:100425.

7. Landen CN Jr., Goodman B, Katre AA, Steg AD, Nick AM, Stone RL, et al. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther 2010;9:3186-99.

8. Jordan MA, Toso RJ, Thrower D, Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A 1993;90:9552-6.

9. Manchukonda NK, Naik PK, Santoshi S, Lopus M, Joseph S, Sridhar B, et al. Rational design, synthesis, and biological evaluation of third generation α-noscapine analogues as potent tubulin binding anti-cancer agents. PLoS One 2013;8:e77970.

10. Pattnaika A, Naikb PK. Transcriptome profiling and identification of differentially expressed genes and pathways with the treatment of N-Alkyl amine-noscapinoids in human breast cancer. Int J Res Anal Rev 2023;10:378-455.

11. Kim D, Langmead B, Salzberg SL. HISAT: A fast spliced aligner with low memory requirements. Nat Methods 2015;12:357-60.

12. Liao Y, Smyth GK, Shi W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014;30:923-30.

13. Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 2015;33:290-5.

14. Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139-40.

15. Sobol MS, Hoshino T, Delgado V, Futagami T, Kadooka C, Inagaki F, et al. Genome characterization of two novel deep-sea sediment fungi, Penicillium pacificagyrus sp. Nov. And Penicillium pacificasedimenti sp. Nov., From South Pacific Gyre subseafloor sediments, highlights survivability. BMC Genomics 2023;24:249.

16. McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013;5:a008656. Erratum in: Cold Spring Harb Perspect Biol 2015;7:a026716.

17. Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin 2008;29:1275-88.

18. Martinez I, Oliveros JC, Cuesta I, de la Barrera J, Ausina V, Casals C, et al. Apoptosis, toll-like, RIG-I-like and NOD-like receptors are pathways jointly induced by diverse respiratory bacterial and viral pathogens. Front Microbiol 2017;8:276.

19. Denisenko TV, Gogvadze V, Zhivotovsky B. Mitophagy in carcinogenesis and cancer treatment. Discov Oncol 2021;12:58.

20. Khan I, Steeg PS. Endocytosis: A pivotal pathway for regulating metastasis. Br J Cancer 2021;124:66-75.

21. Mounetou E, Legault J, Lacroix J, Gaudreault RC. Antimitotic antitumor agents: Synthesis, structure-activity relationships, and biological characterization of N-Aryl-N'-(2-chloroethyl) ureas as new selective alkylating agents. J Med Chem 2001;44:694-702.

22. Viswas RS, Pundir S, Lee H. Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach. J Enzyme Inhib Med Chem 2019;34:620-30.

23. Swain SK, Samal S, Mohanty JN, Choudhury J. Nasopharyngeal carcinoma among the pediatric patients in a non-endemic region: Our experience at a tertiary care teaching hospital in Eastern India. Egypt Pediatr Assoc Gaz 2020;68:1-6.

24. Li HQ, Lv PC, Yan T, Zhu HL. Urea derivatives as anticancer agents. Anticancer Agents Med Chem 2009;9:471-80.

25. El-Naggar M, Almahli H, Ibrahim HS, Eldehna WM, Abdel- Aziz HA. Pyridine-ureas as potential anticancer agents: Synthesis and in vitro biological evaluation. Molecules 2018;23:1459.

26. Anderson JT, Ting AE, Boozer S, Brunden KR, Crumrine C, Danzig J, et al. identification of novel and improved antimitotic agents derived from noscapine. J Med Chem 2005;48:7096-8.

27. Sajadian S, Vatankhah M, Majdzadeh M, Kouhsari SM, Ghahremani MH, Ostad SN. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and papaverine on breast cancer stem cells. Toxicol Mech Methods 2015;25:388-95.

28. Shen W, Liang B, Yin J, Li X, Cheng J. Noscapine increases the sensitivity of drug-resistant ovarian cancer cell line SKOV3/DDP to cisplatin by regulating cell cycle and activating apoptotic pathways. Cell Biochem Biophys 2015;72:203-13.

29. Nagireddy PK, Kumar D, Kommalapati VK, Pedapati RK, Kojja V, Tangutur AD, et al. 9-Ethynyl noscapine induces G2/M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer. Drug Dev Res 2021;83:605-14.

30. Devine SM, Yong C, Amenuvegbe D, Aurelio L, Muthiah D, Pouton C, et al. Synthesis and pharmacological evaluation of noscapine-inspired 5-substituted tetrahydroisoquinolines as cytotoxic agents. J Med Chem 2018;61:8444-56.

31. Rahmanian-Devin P, Baradaran Rahimi V, Jaafari MR, Golmohammadzadeh S, Sanei-Far Z, Askari VR. Noscapine, an emerging medication for different diseases: A mechanistic review. Evid Based Complement Alternat Med 2021;2021:8402517.

32. Nambiar N, Nagireddy PK, Pedapati R, Kantevari S, Lopus M. Tubulin-and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-propargyl noscapine. Life Sci 2020;258:118238.

33. Nguyen TT, Wei S, Nguyen TH, Jo Y, Zhang Y, Park W, et al. Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp Mol Med 2023;55:1595-619.

Article Metrics
24 Views 8 Downloads 32 Total



Related Search

By author names